PubMed:15737842 / 134-474
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T21 | 0-24 | D002285 | denotes | Ductal carcinoma in situ |
T22 | 0-24 | D002285 | denotes | Ductal carcinoma in situ |
T27 | 32-38 | UBERON:0000310 | denotes | breast |
T29 | 40-44 | CVCL_5552 | denotes | DCIS |
T28 | 40-44 | D002285 | denotes | DCIS |
T30 | 40-44 | D002285 | denotes | DCIS |
T33 | 144-154 | C038253 | denotes | heparanase |
T38 | 144-156 | Q9Y251 | denotes | heparanase-1 |
T39 | 144-156 | PR:000008741 | denotes | heparanase-1 |
T52 | 158-162 | Q9C9W5 | denotes | HPR1 |
T53 | 158-162 | PR:000008741 | denotes | HPR1 |
T54 | 158-162 | PR:Q8R3N6 | denotes | HPR1 |
T55 | 158-162 | PR:Q93VM9 | denotes | HPR1 |
T56 | 158-162 | PR:Q9Y251 | denotes | HPR1 |
T57 | 158-162 | PR:Q96FV9 | denotes | HPR1 |
T58 | 158-162 | PR:P17629 | denotes | HPR1 |
T59 | 158-162 | PR:000016310 | denotes | HPR1 |
T60 | 158-162 | PR:G5EC44 | denotes | HPR1 |
T62 | 215-230 | D006497 | denotes | heparan sulfate |
T63 | 215-230 | D006497 | denotes | heparan sulfate |
T64 | 215-230 | CHEBI:28815 | denotes | heparan sulfate |
T66 | 236-249 | CHEBI:37396 | denotes | proteoglycans |
T67 | 236-249 | D011509 | denotes | proteoglycans |
T68 | 236-249 | D011509 | denotes | proteoglycans |
T69 | 257-263 | UBERON:0000310 | denotes | breast |
T71 | 264-284 | GO:0031012 | denotes | extracellular matrix |
T72 | 278-284 | UBERON:0027368 | denotes | matrix |
T74 | 326-330 | CVCL_5552 | denotes | DCIS |
T73 | 326-330 | D002285 | denotes | DCIS |
T75 | 326-330 | D002285 | denotes | DCIS |
UseCases_ArguminSci_Discourse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 118-340 | DRI_Approach | denotes | This study tested whether heparanase-1 (HPR1), an endoglycosidase that specifically degrades the heparan sulfate (HS) proteoglycans in the breast extracellular matrix, was associated with the most aggressive DCIS subtypes. |
PubMed_Structured_Abstracts
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-340 | BACKGROUND | denotes | Ductal carcinoma in situ of the breast (DCIS) forms a heterogeneous group of lesions with varying invasive potential. This study tested whether heparanase-1 (HPR1), an endoglycosidase that specifically degrades the heparan sulfate (HS) proteoglycans in the breast extracellular matrix, was associated with the most aggressive DCIS subtypes. |